FDA Warning Letters Week of 3/30/2020: Pharma, Device, GLP, and Compounding Pharmacy

FDA posted three drug GMP warning letters this week to pharmaceutical firms, one to a compounding pharmacy, one to a GLP site, and two to device manufacturers.

Sourced through Scoop.it from: govzilla.com